Search Medical Condition
Urologic Cancer Clinical Trials
A listing of Urologic Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (137) clinical trials
A Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Subjects With High Risk Non-muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy
Patients who wish to enroll in a research study should discuss the possibilities with their urologist. The TUCC Clinical Research Department staff remains in constant communication with patients throughout their enrollment in clinical trials. These patients receive all study related medication and procedures at no cost. Participation is voluntary and ...
TALAPRO-2
People with prostate cancer are asked to participate in a research study being conducted by Montefiore Medical Center.
Advanced Prostate Cancer
People with advanced prostate cancer are asked to participate in a research study being conducted by White Plains Hospital.
Metastatic Castration-Resistant Prostate Cancer
PMG Research and PMG Research of DuPage Medical Group are looking for men to participate in a research study evaluating the combination of abiraterone (FDA-approved) with olaparib for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations
The purpose of this study is to evaluate the overall response rate (ORR) of INCB054828 as a monotherapy in the treatment of metastatic or surgically unresectable urothelial carcinoma harboring FGF/FGFR alterations.
PRONOUNCE-Malignant Tumor of the Prostate
People with prostate cancer and cardiovascular Disease are asked to participate in a research study being conducted by Montefiore Medical Center.
A prostate cancer study that will evaluate safety and efficacy of niraparib in combination with other anti-cancer agents
Patients who wish to enroll in a research study should discuss the possibilities with their urologist. The TUCC Clinical Research Department staff remains in constant communication with patients throughout their enrollment in clinical trials. These patients receive all study related medication and procedures at no cost. Participation is voluntary and ...
The ProVent Study is designed to look at subjects who receive sipuleucel-T compared to control subjects followed on active surveillance as standard of care.
Patients who wish to enroll in a research study should discuss the possibilities with their urologist. The TUCC Clinical Research Department staff remains in constant communication with patients throughout their enrollment in clinical trials. These patients receive all study related medication and procedures at no cost. Participation is voluntary and ...
Muscle-Invasive Bladder Cancer
A research study is evaluating an investigational medication used in combination with Nivolumab (OPDIVO®) in those diagnosed with Muscle-Invasive Urothelial Carcinoma of the bladder.
